Cynthia Owusu is an Oncology physician affiliated with University Hospitals of Cleveland. OpenAlex indexes 134 publications with 5,189 citations (h-index 31); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
11100 Euclid Ave
Cleveland, OH 441061716
Telephone
216-844-8500Provider last certified this registry record 11 Jan 2021.
Clinical trials
- Physical Activity Intervention to Reduce Functional Health Disparities Among Breast Cancer Survivors
Sponsor: Case Comprehensive Cancer Center
- Attitudes, Beliefs, and Preferences of Older Stage I-III Breast Cancer Survivors Towards Physical Activity
Sponsor: Case Comprehensive Cancer Center
- Outpatient Health Care Program for Older Patients Receiving Chemotherapy for Newly Diagnosed Breast Cancer or Colon Cancer
Sponsor: Case Comprehensive Cancer Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year20241 payment
- Novartis Pharmaceuticals CorporationProgram year20231 payment
- Gilead Sciences, Inc.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
76.2%Aromatase Inhibitor52.5%Anastrozole65%Letrozole26%Exemestane9%Part D<11 patientsKinase inhibitor18.9%Ibrance48%Verzenio39%Kisqali13%Part D<11 patients+ 1 more class in this area
Nervous system
9.5%Phenothiazine4.5%Prochlorperazine Maleate100%Part D≥16 patientsAtypical Antipsychotic3%Olanzapine100%Part D<11 patients+ 1 more class in this area
Blood & clotting
4.5%Factor Xa inhibitor4.5%Eliquis100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2015–2019 per NIH RePORTER. The latest:
- Reducing Functional Health Disparities among Older Breast Cancer Survivors
Case Western Reserve University
FY2019$547,273R01MD009699 - Reducing Functional Health Disparities among Older Breast Cancer Survivors
Case Western Reserve University
FY2018$556,712R01MD009699 - Reducing Functional Health Disparities among Older Breast Cancer Survivors
Case Western Reserve University
FY2017$556,712R01MD009699
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Exercise and Nutrition to Improve Cancer Treatment-Related Outcomes (ENICTO)
JNCI Journal of the National Cancer Institute
2024 - NCCN Guidelines® Insights: Older Adult Oncology, Version 1.2021
Journal of the National Comprehensive Cancer Network
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Sophia Sundararajan, MD
University Hospitals of Cleveland
Michael Lederman, MD
University Hospitals of Cleveland
Anthony Furlan
University Hospitals of Cleveland
Hans Luders
University Hospitals of Cleveland
Carl June, MD
University of Pennsylvania
Christopher Benz, MD
Buck Institute for Research on Aging
Christina Fitzmaurice, MD
Gundersen Health System
Beth Karlan, MD
Cedars-Sinai Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”